Dongsung Chemical동성케미컬

Dongsung Chemical shows solid trailing profitability and a low valuation, but free cash flow is negative and the share price has fallen over the past year.

Dongsung Chemical, a KOSPI-listed chemicals company, reported trailing twelve-month revenue of about ₩1.25T and operating income of about ₩136B to H1 2026, with a 10.8% operating margin. Its 2025 revenue rose 13.6% to ₩1.21T, but the share price is down 10.6% over one year, trading at ₩3,645 within a 52-week range of ₩3,150 to ₩4,817. The company profile and news headlines were not provided in the data, so the business description below is limited to the financial figures.

What stands out

• Trailing operating margin of 10.8% is up from 9.2% in 2025 and 8.5% in 2024, according to the filed figures.
• Trailing free cash flow is negative at about -₩33B, even though net income is positive at about ₩42B.
• Cash of about ₩114B is higher than borrowings of about ₩101B, and liabilities are 73.2% of equity.
• Valuation metrics are low: P/E about 4.4, P/B about 0.4, and a dividend yield of 4.1%. The DCF base case in the data is ₩10,039, well above the current price, but this is a model output and not a forecast.
• Recent filings include a half-year report for June 2026 and a cash dividend decision, and several largest-shareholder holding changes.

What to watch

• The 2026 full-year results and the next quarterly report, since trailing free cash flow is negative and the trend is not yet clear.
• Further largest-shareholder and insider holding filings, which appeared frequently in the recent filing list.
• The dividend payment details following the July 2026 cash dividend decision. Foreign ownership, short-selling and investor flow data were not available in the pack.